Search Results
Feb 25, 2026, 11:00 ET CleanStart Announces Strategic Partnership with Sysdig to Deliver Continuous Software Supply Chain Verification from Build to Runtime
gap..."Software supply chains have become prime targets for cyberattacks, with adversaries increasingly exploiting open-source dependencies, CI/CD pipelines, and container images to introduce malicious code into trusted environments. At the same time, organizations face growing pressure to prove
More news about: CleanStart
Feb 25, 2026, 09:00 ET Sealed Air Announces Stockholder Approval of Acquisition By CD&R
which Sealed Air stockholders voted in favor of all proposals, including a proposal to approve the Company's pending acquisition by an affiliate of CD&R.
More news about: Sealed Air
Feb 25, 2026, 08:00 ET Becton, Dickinson and Company Announces Early Tender Results and Upsizing of Offer SubCap and Aggregate Offer Cap
Registered: 075887CE7144A: 075887CD9Reg S: U0740RAE2
More news about: BD (Becton, Dickinson and Company)
Feb 25, 2026, 00:01 ET IBM 2026 X-Force Threat Index: AI-Driven Attacks are Escalating as Basic Security Gaps Leave Enterprises Exposed
identified a nearly 4X increase in large supply chain or third-party compromises since 2020, mainly driven by attackers exploiting trust relationships and CI/CD automation across development workflows and SaaS integrations. With AI-powered coding tools accelerating software creation, and occasionally introducing
More news about: IBM
Feb 24, 2026, 19:30 ET Antengene Announces Clinical Collaboration with Junshi Biosciences to Explore the Synergistic Potential of ATG-037 (Oral CD73 Inhibitor) In Combination with JS207 (PD-1/VEGF BsAb)
immunosuppression.ATG-037, Antengene's orally administered small-molecule CD73 inhibitor, offers significant advantages over anti-CD73 monoclonal antibodies. In preclinical studies, ATG-037 demonstrated stronger inhibition of cell-surface CD73 enzymatic activity and overcame the "hook effect" commonly observed
More news about: Antengene Corporation Limited
Feb 24, 2026, 12:00 ET New Linux Foundation Report Shows Active Open Source Contribution Delivers 2-5x ROI, While Passive Consumption Increases Costly Technical Debt
https://www.linuxfoundation.org/research/contribution-roi.We thank our sponsors, CD Foundation, CNCF, FINOS, Intel, LF Decentralized Trust, LF Networking, Mercedes-Benz, OpenInfra, OpenSSF, TODO Group, and Toyota, and survey
More news about: The Linux Foundation
Feb 24, 2026, 09:00 ET Class Counsel announces proposed Settlement of Stockholder Class Action on Behalf of Former Holders of Covetrus, Inc. Securities
v.CLAYTON, DUBILIER & RICE, LLC, CD&R VFC HOLDINGS, L.P., CD&R INVESTMENT ASSOCIATES IX, LTD., RAVI SACHDEV, and SANDRA PETERSON,
More news about: Labaton Keller Sucharow LLP
Feb 24, 2026, 08:00 ET Gluware Wins Most Innovative Automation Product in SiliconANGLE Media's 2026 Tech Innovation CUBEd Awards
extensibility through a complete builder ecosystem for teams desiring customization.The platform combines advanced tooling with enterprise flexibility: CI/CD integrations, Visual Studio Code extensions, native Git support with GitHub and Bitbucket, and AI-powered Co-Pilots that generate automation through
More news about: Gluware, Inc.
Feb 24, 2026, 07:15 ET ADC Therapeutics to Participate in March Investor Conferences
conjugates (ADCs), transforming treatment for patients through our focused portfolio with ZYNLONTA (loncastuximab tesirine-lpyl).ADC Therapeutics' CD19-directed ADC ZYNLONTA received accelerated approval by the FDA and conditional approval from the European Commission for the treatment of relapsed
More news about: ADC Therapeutics SA
Feb 24, 2026, 02:28 ET Gentoo Media publishes Q4 2025 Interim Report
https://mb.cision.com/Public/15972/4311806/b457ced12cd61ab7.pdfGentoo Media Q42025
More news about: Gentoo Media Inc
Feb 24, 2026, 02:26 ET Gentoo Media publishes Q4 2025 Interim Report
https://mb.cision.com/Public/15972/4311806/b457ced12cd61ab7.pdfGentoo Media Q42025
More news about: Gentoo Media Inc
Feb 23, 2026, 17:00 ET Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer
VIR) today announced they have entered into a global strategic collaboration to advance VIR-5500, an investigational PRO-XTEN® dual-masked CD3 T-cell engager (TCE) targeting PSMA for the treatment of prostate cancer. The collaboration aims to accelerate the development of VIR-5500 and further
More news about: Astellas Pharma Inc.
Feb 23, 2026, 14:15 ET NetActuate Launches Global Edge Storage
resources with no added complexity. Each option can be provisioned in just a few clicks through the NetActuate customer portal or automated via API and CI/CD workflows.PricingUnlike other industry storage options, NetActuate's storage is priced only on the amount of storage being used
More news about: NetActuate
Feb 23, 2026, 08:00 ET Omalizumab Triggers T Cell Modification, Increasing the Reaction Thresholds to Common Food Allergens
significant decreases in IL-4⁺peanut-reactive CD4⁺ T cells, IL-4⁺CD4⁺T cells and Fcepsilon;RI⁺ myeloid and plasmacytoid DCs compared to the baseline, with no such changes in the placebo group. After Stage 2, both treatments reduced IL-4⁺peanut-reactive and IL-4⁺CD4⁺T cells; Fcepsilon;RI⁺mDCs/pDCs decreased
More news about: American Academy of Allergy, Asthma & Immunology (AAAAI)
Feb 23, 2026, 07:15 ET ADC Therapeutics Announces Amended HealthCare Royalty Financing Agreement
control payment described above.About ZYNLONTA® ZYNLONTA® is a CD19-directed antibody drug conjugate (ADC). Once bound to a CD19-expressing cell, ZYNLONTA is internalized by the cell, where enzymes release a pyrrolobenzodiazepine (PBD) payload. The
More news about: ADC Therapeutics SA
Feb 21, 2026, 08:00 ET TREMFYA® (guselkumab) long-term data show sustained clinical and endoscopic remission in ulcerative colitis through 3 years
inflammation at the cellular source by blocking IL-23 and binding to CD64 (a receptor on cells that produce IL-23). Findings for the dual-acting mechanism are limited to in vitro studies that demonstrate guselkumab binds to CD64, which is expressed on the surface of IL-23 producing cells in an inflammatory
More news about: Johnson & Johnson
Feb 20, 2026, 12:14 ET Samsung México: La temporada de premios se vive mejor con una verdadera pantalla QLED
ambiente.1 Certificación TÜV Rheinland – Real Quantum Dot Display Samsung 2 Certificación SGS – No Cd (not detected) Samsung Real QLEDFoto -
More news about: Samsung Mexico
Feb 20, 2026, 10:58 ET Discovery Could Make Immune Checkpoint Inhibitors Safer
mimics immune checkpoint inhibitor–induced myocarditis. Then, in a series of advanced experiments, the team pinpointed a key driver of the complication: CD8 T cell–derived tumor necrosis factor (TNF). Importantly, the team found that this complication from checkpoint inhibitors is not caused by tumors
More news about: Cincinnati Children's Hospital Medical Center
Feb 20, 2026, 10:46 ET VIRGIN MUSIC GROUP COMPLETES ACQUISITION OF DOWNTOWN
& Label Services, Distribution, and Music Publishing. The company's portfolio of businesses includes FUGA, Downtown Artist & Label Services, CD Baby, Downtown Music Publishing and Songtrust.With extensive leadership experience across both Downtown Music and FUGA, van Rijn has been a key
More news about: Virgin Music Group
Feb 20, 2026, 10:18 ET VIRGIN MUSIC GROUP COMPLETES ACQUISITION OF DOWNTOWN
& Label Services, Distribution, and Music Publishing. The company's portfolio of businesses includes FUGA, Downtown Artist & Label Services, CD Baby, Downtown Music Publishing and Songtrust.With extensive leadership experience across both Downtown Music and FUGA, van Rijn has been a key
More news about: Virgin Music Group
Feb 19, 2026, 12:15 ET Patients with Crohn's disease maintained steroid-free remission for three years with Lilly's Omvoh (mirikizumab-mrkz)
NCT06937086) and COMMIT-CD (
More news about: Eli Lilly and Company
Feb 19, 2026, 09:07 ET CD Valet Survey Reveals that Only 33% of Financial Institutions Offer Digital Account Opening for CDs
players.About CD Valet CD Valet is a CD marketplace that features verified CD rates from federally insured banks and credit unions. With tens of thousands of CD offers tracked across the country, CD Valet gives savers a clear view of top rates and helps them explore high-yield CD options with
More news about: CD Valet
Feb 19, 2026, 07:33 ET Vie Ventures Names Jeff Bluestone, PhD, as Managing Director
played a central role in translating foundational immunology into approved medicines. Among his accomplishments, Dr. Bluestone defined key aspects of CD3 signaling and immune modulation, created teplizumab, the first FDA-approved therapy shown to delay the onset of type 1 diabetes, and informed therapies
More news about: Vie Ventures
Feb 18, 2026, 16:30 ET WYNDHAM HOTELS & RESORTS REPORTS FOURTH QUARTER RESULTS
8Total fee-related and other revenues (c)(d)
More news about: Wyndham Hotels & Resorts
Feb 18, 2026, 15:48 ET El nuevo programa BofA Rewards™ llegará a millones de clientes más y mejorará el reconocimiento de las relaciones
of America: cuentas de cheques, cuenta de ahorros Bank of America Advantage Banking, cuenta de ahorros money market savings, certificados de depósito (CD) y Cuentas Individuales de Jubilación (Individual Retirement Accounts, o IRA)Cuentas de inversión de Merrill®, como la Cuenta de Administración
More news about: Bank of America Corporation